NCT06339034View on ClinicalTrials.gov

Repurposing Lithium for Parkinson's Disease: a RCT

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 3, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

February 28, 2026

Conditions
Parkinson Disease
Interventions
DIETARY_SUPPLEMENT

Lithium

5mg of elemental lithium/capsule

OTHER

Placebo

Cellulose-filled capsules

Trial Locations (1)

14221

UBMD Neurology, Williamsville

All Listed Sponsors
collaborator

Cure Parkinson's

OTHER

lead

State University of New York at Buffalo

OTHER

NCT06339034 - Repurposing Lithium for Parkinson's Disease: a RCT | Biotech Hunter | Biotech Hunter